Table 2. Changes in distribution of the molecular types of breast cancers.
Surrogate definitions based on St. Gallen consensus | |||
---|---|---|---|
Before 2011 No. (%) | St. Gallen 2011 No. (%) | St. Gallen 2013 No. (%) | |
Luminal A type | 149 (55.8) | 76 (28.5) | 58 (21.7) |
Luminal B type | 29 (10.9) | 102 (38.2) | 120 (44.9) |
HER2 type | 39 (14.6) | 39 (14.6) | 39 (14.6) |
Triple-negative type* | 50 (18.7) | 50 (18.7) | 50 (18.7) |
HER2=human epidermal growth factor receptor 2.
*Including basal-like type.